3-41883906-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017886.4(ULK4):​c.1624G>A​(p.Ala542Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.807 in 1,606,958 control chromosomes in the GnomAD database, including 533,317 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A542A) has been classified as Benign.

Frequency

Genomes: 𝑓 0.69 ( 39499 hom., cov: 33)
Exomes 𝑓: 0.82 ( 493818 hom. )

Consequence

ULK4
NM_017886.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0120

Publications

87 publications found
Variant links:
Genes affected
ULK4 (HGNC:15784): (unc-51 like kinase 4) This gene encodes a member of the unc-51-like serine/threonine kinase (STK) family. Members of this protein family play a role in neuronal growth and endocytosis. The encoded protein is likely involved in neurite branching, neurite elongation and neuronal migration. Genome-wide association studies (GWAS) indicate an association of variations in this gene with blood pressure and hypertension. Sequence variations in this gene may also be be associated with psychiatric disorders, including schizophrenia and bipolar disorder. Pseudogenes associated with this gene have been identified and are located on chromosome 15. [provided by RefSeq, Jul 2016]
ULK4 Gene-Disease associations (from GenCC):
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.9328033E-7).
BP6
Variant 3-41883906-C-T is Benign according to our data. Variant chr3-41883906-C-T is described in ClinVar as Benign. ClinVar VariationId is 403584.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.823 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017886.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ULK4
NM_017886.4
MANE Select
c.1624G>Ap.Ala542Thr
missense
Exon 17 of 37NP_060356.2
ULK4
NM_001322500.2
c.1624G>Ap.Ala542Thr
missense
Exon 17 of 36NP_001309429.1
ULK4
NM_001322501.2
c.718G>Ap.Ala240Thr
missense
Exon 16 of 36NP_001309430.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ULK4
ENST00000301831.9
TSL:2 MANE Select
c.1624G>Ap.Ala542Thr
missense
Exon 17 of 37ENSP00000301831.4
ULK4
ENST00000420927.5
TSL:1
c.1624G>Ap.Ala542Thr
missense
Exon 17 of 18ENSP00000412187.1

Frequencies

GnomAD3 genomes
AF:
0.690
AC:
104866
AN:
152048
Hom.:
39481
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.357
Gnomad AMI
AF:
0.785
Gnomad AMR
AF:
0.788
Gnomad ASJ
AF:
0.808
Gnomad EAS
AF:
0.834
Gnomad SAS
AF:
0.811
Gnomad FIN
AF:
0.775
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.829
Gnomad OTH
AF:
0.709
GnomAD2 exomes
AF:
0.796
AC:
198487
AN:
249506
AF XY:
0.801
show subpopulations
Gnomad AFR exome
AF:
0.351
Gnomad AMR exome
AF:
0.860
Gnomad ASJ exome
AF:
0.816
Gnomad EAS exome
AF:
0.818
Gnomad FIN exome
AF:
0.777
Gnomad NFE exome
AF:
0.828
Gnomad OTH exome
AF:
0.799
GnomAD4 exome
AF:
0.820
AC:
1192701
AN:
1454792
Hom.:
493818
Cov.:
42
AF XY:
0.821
AC XY:
594621
AN XY:
724146
show subpopulations
African (AFR)
AF:
0.335
AC:
11156
AN:
33330
American (AMR)
AF:
0.855
AC:
38228
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.812
AC:
21169
AN:
26074
East Asian (EAS)
AF:
0.853
AC:
33839
AN:
39674
South Asian (SAS)
AF:
0.817
AC:
70373
AN:
86088
European-Finnish (FIN)
AF:
0.786
AC:
41996
AN:
53412
Middle Eastern (MID)
AF:
0.655
AC:
3770
AN:
5760
European-Non Finnish (NFE)
AF:
0.836
AC:
924521
AN:
1105578
Other (OTH)
AF:
0.792
AC:
47649
AN:
60172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
9350
18699
28049
37398
46748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20814
41628
62442
83256
104070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.689
AC:
104900
AN:
152166
Hom.:
39499
Cov.:
33
AF XY:
0.691
AC XY:
51388
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.357
AC:
14804
AN:
41480
American (AMR)
AF:
0.788
AC:
12051
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.808
AC:
2806
AN:
3472
East Asian (EAS)
AF:
0.835
AC:
4322
AN:
5178
South Asian (SAS)
AF:
0.812
AC:
3920
AN:
4828
European-Finnish (FIN)
AF:
0.775
AC:
8214
AN:
10592
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.829
AC:
56385
AN:
68008
Other (OTH)
AF:
0.711
AC:
1504
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1368
2736
4103
5471
6839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
796
1592
2388
3184
3980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.787
Hom.:
236847
Bravo
AF:
0.677
TwinsUK
AF:
0.831
AC:
3080
ALSPAC
AF:
0.839
AC:
3235
ESP6500AA
AF:
0.376
AC:
1436
ESP6500EA
AF:
0.826
AC:
6779
ExAC
AF:
0.788
AC:
95231
Asia WGS
AF:
0.805
AC:
2802
AN:
3478
EpiCase
AF:
0.811
EpiControl
AF:
0.814

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.17
DANN
Benign
0.21
DEOGEN2
Benign
0.00023
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.00097
N
LIST_S2
Benign
0.091
T
MetaRNN
Benign
5.9e-7
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-1.1
N
PhyloP100
-0.012
PrimateAI
Benign
0.35
T
PROVEAN
Benign
2.2
N
REVEL
Benign
0.10
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.037
MPC
0.035
ClinPred
0.00081
T
GERP RS
0.24
Varity_R
0.027
gMVP
0.082
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1052501; hg19: chr3-41925398; COSMIC: COSV57217932; API